Genomma Lab Internacional, SAB de CV (BMV:LABB), a pharmaceutical and personal care products company in Latin America, announced on Tuesday that it has filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN0.200000 per share on its common stock, representing a total amount of MXN200,000,000.
This is unchanged from the previous quarterly dividend.
The dividend will be paid to shareholders of record at the close of business on 17 September 2024.
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
Labcorp announces cash dividend
Gilead expands global access to lenacapavir for HIV prevention